Prior infection with cytomegalovirus is not a major risk factor for angiographically demonstrated coronary artery atherosclerosis

Journal of Infectious Diseases

Volumn 177, Issue 1, 1998, Pages 209-212

  Adler, Stuart P ^a   Hur, Jae Kyun ^b   Wang, Jian Ben ^b   Vetrovec, George W ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATHEROGENESIS; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BLOOD FLOW; CORONARY RISK; CYTOMEGALOVIRUS; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR;

EID: 17344365601     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/517355     Document Type: Article

References (16)

1. Grattan MT. Accelerated graft atherosclerosis following cardiac transplantation: clinical perspectives. Clin Cardiol 1991;14(suppl II):16-20.
2. Zhou YF, Leon MB, Waclawiw MA, et al. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med 1996;335:624-30.
3. Epstein SE, Speir E, Zhou YF, Guetta E, Leon M, Finkel T. The role of infection in restenosis and atherosclerosis: focus on cytomegalovirus. Lancet 1996;348:13-7.
4. Bodurtha J, Adler SP, Nance WE. Seroepidemiology of cytomegalovirus and herpes simples virus in twins and their families. Am J Epidemiol 1988;128:268-76.
5. Adam E, Probtsfield JL, Burek J, et al. High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet 1987;2:291-3.
6. Adler SP, McVoy M. Detection of cytomegalovirus antibody by enzyme immunoassay and lack of evidence for an effect resulting from strain heterogeneity. J Clin Microbiol 1986;24:870-2.
7. Adler SP, McVoy M, Biro VG, Britt WJ, Hider P, Marshall D. Detection of cytomegalovirus antibody with latex agglutination. J Clin Microbiol 1985;22:68-70.
8. Wang JB, Adler SP, Hempfling S, et al. Mucosal antibodies to cytomegalovirus glycoprotein B occur following both natural infection and immunization with human cytomegalovirus vaccines. J Infect Dis 1996;174:387-92.
9. Melnick JL, Adam E, DeBakey ME. Possible role of cytomegalovirus in atherogenesis. JAMA 1990;263:2204-7.
10. Wu TC, Hruban RH, Ambinder RF, et al. Demonstration of cytomegalovirus nucleic acids in the coronary arteries of transplanted hearts. Am J Pathol 1992;140:739-47.
11. Hendrix MGR, Salimans MMM, van Boven CPA, Bruggeman CA. High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Am J Pathol 1990;136:23-38.
12. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9.
13. Marshall GS, Rabalais GP, Stout GG, et al. Antibodies to recombinant-derived glycoprotein B after natural human cytomegalovirus infection correlate with neutralizing activity. J Infect Dis 1992;165:381-4.
14. Thom DH, Grayston JT, Siscovick DS, Wang SP, Weiss NS, Daling JR. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA 1992;268:68-72.
15. Sorlie PD, Adams E, Melnick SL, et al. Cytomegalovirus/herpesvirus and carotid atherosclerosis: the ARIC Study. J Med Virol 1994;42:33-7.
16. Nieto FJ, Adam E, Sorlie P, et al. Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. Circulation 1996;94:922-7.